Catalyst
Slingshot members are tracking this event:
Novo Nordisk's (NVO) NDA for Faster-Acting Insulin Rejected by FDA
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| NVO |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 11, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Nda, Rejection, Fda, Faster-acting Insulin
